Logo

American Heart Association

  2
  0


Final ID:

Innovation and Product Development in Cardiac Therapeutics

  • Pina, Ileana  ( Thomas Jefferson University , Cleveland Heights , Ohio , United States )
  • Srivastava, Deepak  ( GLADSTONE INSTITUTES , San Francisco , California , United States )
  • Haldar, Saptarsi  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Van, Eva  ( HUBRECHT INSTITUTE , Utrecht , Netherlands )
  • Author Disclosures:
    Ileana Pina: DO have relevant financial relationships ; Advisor:Boehringer Ingelheim:Active (exists now) ; Employee:Thomas Jefferson University:Active (exists now) ; Advisor:Bayer:Past (completed) | Deepak Srivastava: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Tenaya Therapeutics - co-founder, board member, stockholder, scientific advisory board member:Active (exists now) | Saptarsi Haldar: No Answer | Eva Van: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Research and Innovation Through the Pipeline

Friday, 11/15/2024 , 02:00PM - 03:00PM

Early Career

More abstracts on this topic:
More abstracts from these authors:
A CRISPR-Activation CROP-seq Screen Identifies HMGN1 as a Dosage-Sensitive Regulator of Heart Defects in Down Syndrome

Ranade Sanjeev, Mital Rahul, Boileau Ryan, Koback Frances, Padmanabhan Arun, Merriman Alexander, Wallace Langley, Nguyen Annie, Poulis Nikolaus, Gifford Casey, Pollard Katherine, Li Feiya, Srivastava Deepak, Whalen Sean, Angelo Pelonero, Ye Lin, Huang Yu, Brand Abigail, Nishino Tomohiro, Costa Mauro

Panel

Pina Ileana, Harrington Robert, Benjamin Ivor, Topol Eric, Reza Nosheen, Gulati Martha, Khera Amit, Hill Joseph

You have to be authorized to contact abstract author. Please, Login
Not Available